Table of Contents
<< Previous Issue | Mar 2013 (Vol: 2013, Issue: 3) | Next Issue >> |
- Section: Licensing
-
Jazz and Concert Collaborate to Develop Deuterium-Modified Version of Xyrem®
-
Resolve Therapeutics Secures Path to Liquidity via Option Deal with Takeda
- Section: Mergers & Acquisitions
-
Cubist Gains Option to Acquire Adynxx with Diversification in Mind
-
Mylan Bolsters Global Injectables Business with Deal to Acquire Agila Specialities from Strides Arcolab